Wednesday, May 28, 2008

NNVC news

NanoViricides in Discussions with Pharma about EKC Eye Drug Candidate

Wednesday May 28, 7:00 am ET

Non-Disclosure Agreements Signed; Meetings Scheduled, says Company

WEST HAVEN, Conn.--(BUSINESS WIRE)--NanoViricides, Inc. (OTC BB: NNVC.OB) (the Company), said that it has signed or has in attorney-review non-disclosure agreements with major pharmaceutical companies to enable further discussions regarding the Companys nanoviricide drug candidate against Epidemic Kerato-Conjunctivitis (EKC). We have already scheduled meetings to discuss the results of our recent animal studies against EKC, said Eugene Seymour, MD, MPH, CEO of the Company, adding, We have significant interest from several large pharma companies in both USA and abroad.

2 comments:

Anonymous said...

What do you make of the recent moves of price in NNVC? I got in at 1.20 and I just recently freed up some money to get in again but I'm wondering if you think I should wait for the price to pull back again (if it will?).

Your thoughts would be appreciated but of course I take full responsibility for my decisions.

Thanks again,

Matthew

Allan said...

In your situation, I would consider putting half in now, then half in on any pullback. After due consideration, I would put it all i on the open tomorrow.